Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis

European Journal of Human Genetics

Volumn 18, Issue 6, 2010, Pages 680-684

  McDougal, Kathryn E ^a   Green, Deanna M ^a   Vanscoy, Lori L ^b   Fallin, M Daniele ^c   Grow, Michael ^c   Cheng, Suzanne ^c   Blackman, Scott M ^a   Collaco, J Michael ^a   Henderson, Lindsay B ^a   Naughton, Kathleen ^a   Cutting, Garry R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Confounding; Immunity; Infection

Indexed keywords

MANNOSE BINDING LECTIN 2; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; AGE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; PSEUDOMONAS INFECTION;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; FEMALE; GENETIC HETEROGENEITY; GENETIC VARIATION; HUMANS; MALE; MANNOSE-BINDING LECTIN; MODELS, BIOLOGICAL; MODELS, GENETIC; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SIBLINGS; TWIN STUDIES AS TOPIC; TWINS; YOUNG ADULT;

PSEUDOMONAS AERUGINOSA;

EID: 77952668529     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.226     Document Type: Article

References (38)

1. Vanscoy LL, Blackman SM, Collaco JM et al: Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med 2007; 10: 1036-1043. (Pubitemid 46741755)
2. Garred P, Pressler T, Madsen HO et al: Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104: 431-437. (Pubitemid 29534327)
3. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S: Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004; 3: 260-267. (Pubitemid 38916043)
4. Horiuchi T, Gondo H, Miyagawa H et al: Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immun 2005; 2: 162-166. (Pubitemid 40439543)
5. Li Z, Kosorok MR, Farrell PM et al: Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005; 5: 581-588. (Pubitemid 40171240)
6. Buranawuti K, Boyle MP, Cheng S et al: Variants in mannose-binding lectin and tumor necrosis factor\{alpha\} affect survival in cystic fibrosis. J Med Genet 2006; 3: 209-214. (Pubitemid 46580531)
7. Carlsson M, Sjoholm AG, Eriksson L et al: Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin Exp Immunol 2005; 2: 306-313. (Pubitemid 40222848)
8. Dorfman R, Sandford A, Taylor C et al: Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest 2008; 3: 1040-1049. (Pubitemid 351364611)
9. Trevisiol C, Boniotto M, Giglio L, Poli F, Morgutti M, Crovella S: MBL2 polymorphisms screening in a regional Italian CF center. J Cyst Fibros 2005; 3: 189-191. (Pubitemid 41200481)
10. Gabolde M, Guilloud-Bataille M, Feingold J, Besmond C: Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study. BMJ 1999; 7218: 1166-1167. (Pubitemid 29502020)
11. Davies JC, Turner MW, Klein N: Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur Respir J 2004; 5: 798-804. (Pubitemid 39504434)
12. Muhlebach MS, MacDonald SL, Button B et al: Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent. Clin Exp Immunol 2006; 2: 302-307. (Pubitemid 44060121)
13. Yarden J, Radojkovic D, De Boeck K et al: Polymorphisms in the mannose binding lectin gene affect the cystic fibrosis pulmonary phenotype. J Med Genet 2004; 8: 629-633. (Pubitemid 39061270)
14. Olesen HV, Jensenius JC, Steffensen R, Thiel S, Schiotz PO: The mannan-binding lectin pathway and lung disease in cystic fibrosis-dysfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier. Clin Immunol 2006; 3: 324-331. (Pubitemid 44738718)
15. Drumm ML, Konstan MW, Schluchter MD et al: Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005; 14: 1443-1453. (Pubitemid 41400918)
16. Cutting GR: Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 2005; 6: 237-260.
17. Colhoun HM, McKeigue PM, Davey SG: Problems of reporting genetic associations with complex outcomes. Lancet 2003; 9360: 865-872.
18. Greenland S, Morgenstern H: Confounding in health research. Annu Rev Public Health 2001; 22: 189-212.
19. Vanscoy LL, Lai T, Bowers A, Cutting GR: Modifier genes may contribute substantially to variation in cystic fibrosis (CF) lung disease estimated by CF-specific % for FEV1. Proc Am Thorac Soc 2006; 3: A408.
20. Cystic Fibrosis Foundation: Cystic Fibrosis Foundation Patient Registry Annual Data Report 2006, Bethesda, MD: Cystic Fibrosis Foundation, 2006.
21. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B: Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 6: 725-734. (Pubitemid 13101554)
22. Kulich M, Rosenfeld M, Campbell J et al: Disease-specific reference equations for lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005; 7: 885-891. (Pubitemid 41369073)
23. Sumiya M, Super M, Tabona P et al: Molecular basis of opsonic defect in immuno-deficient children. Lancet 1991; 8757: 1569-1570.
24. Lipscombe RJ, Sumiya M, Hill AV et al: High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992; 9: 709-715.
25. Madsen HO, Garred P, Kurtzhals JA et al: A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994; 1: 37-44. (Pubitemid 24163171)
26. Madsen HO, Garred P, Thiel S et al: Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 6: 3013-3020.
27. Baxter N, Sumiya M, Cheng S et al: Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes. Clin Exp Immunol 2001; 3: 529-534. (Pubitemid 34008728)
28. Wang X, Myers A, Saiki RK, Cutting GR: Development and evaluation of a PCR-based, line probe assay for the detection of 58 alleles in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Clin Chem 2002; 7: 1121-1123. (Pubitemid 34680917)
29. Bremer LA, Blackman SM, Vanscoy LL et al: Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum Mol Genet 2008.
30. Hernan MA, Hernandez-Diaz S, Werler MM, Mitchell AA: Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 2002; 2: 176-184. (Pubitemid 34072741)
31. O'Brien RG: A tour of UnifyPow: a SAS module/macro for sample-size analysis. Proceedings of the 23rd Annual SAS Users Group International Conference, Cary, NC 1998; 1346-1355.
32. Collaco JM, Vanscoy L, Bremer L et al: Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA 2008; 4: 417-424. (Pubitemid 351185950)
33. Blackman SM, Deering-Brose R, McWilliams R et al: Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology 2006; 4: 1030-1039. (Pubitemid 44498693)
34. Renders NH, Sijmons MA, van Belkum A, Overbeek SE, Mouton JW, Verbrugh HA: Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings. Res Microbiol 1997; 5: 447-454. (Pubitemid 27314925)
35. Thomassen MJ, Demko CA, Doershuk CF, Root JM: Pseudomonas aeruginosa isolates: comparisons of isolates from campers and from sibling pairs with cystic fibrosis. Pediatr Pulmonol 1985; 1: 40-45.
36. Nixon GM, Armstrong DS, Carzino R et al: Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 5: 699-704. (Pubitemid 32417671)
37. Kosorok MR, Zeng L, West SE et al: Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001; 4: 277-287. (Pubitemid 32938876)
38. Ballmann M, Rabsch P, von der HH: Long-term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Thorax 1998; 9: 732-737. (Pubitemid 28408712)